Tag: its-new
-
Valeant wants Perrigo’s Papa as its new CEO: CNBC, citing Dow Jones
(Reuters) – Valeant Pharmaceuticals International Inc is seeking to name Perrigo Co Plc's Joseph Papa as its new chief executive, CNBC tweeted, citing Dow Jones.
-
Valeant wants Perrigo’s Papa as its new CEO: CNBC, citing Dow Jones
(Reuters) – Valeant Pharmaceuticals International Inc is seeking to name Perrigo Co Plc's Joseph Papa as its new chief executive, CNBC tweeted, citing Dow Jones.
-
Countries on verge of beating malaria face new threat, study says
By Sebastien Malo NEW YORK (Thomson Reuters Foundation) – Nations on the verge of eliminating malaria risk falling short of their goal, just as it lies within reach, due to funding being shifted elsewhere, researchers said on Thursday. Global aid has moved to areas where malaria remains widespread, while internal domestic funding gets diverted to…
-
AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep
By Ben Hirschler CAMBRIDGE, England (Reuters) – AstraZeneca, working with genome pioneer Craig Venter, is launching a massive gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential of genetic variations to unlock routes to new medicines. The initiative, announced on Friday, involves sequencing up to 2 million human genomes…
-
UK agency backs cancer drug after Sanofi cuts price
LONDON (Reuters) – Britain's healthcare cost watchdog NICE said on Friday it had changed its mind and decided to recommend Sanofi's prostate cancer drug Jevtana after the French company agreed to a further discount. The National Institute for Health and Care Excellence (NICE) said the improved discount was “an excellent example of how pharma companies…